| Popis: |
Tsegaye Melaku,1 Legese Chelkeba,1 Zeleke Mekonnen,2 Kabaye Kumela1 1Department of Clinical Pharmacy, School of Pharmacy, Institute of Health, Jimma University, Jimma, Ethiopia; 2School of Medical Laboratory Sciences, Institute of Health, Jimma University, Jimma, EthiopiaCorrespondence: Tsegaye MelakuJimma University, Jimma, EthiopiaTel +251 913765609Email tsegayemlk@yahoo.comBackground: Antiretroviral therapy has decreased human immunodeficiency virus related mortality. However, the incidence of diabetes mellitus is increasing among people living with human immunodeficiency virus and adds complexity to the standards of care.Objective: The study was aimed to determine the glycemic control and delivery of clinical care among people living with diabetes and human immunodeficincy virus in Ethiopia.Methods: A comparative prospective cohort study was conducted among patients living with diabetes at follow-up clinics of Jimma Medical Center in two study arms. The first arm was people living with diabetes and human immunodeficiency virus. The second arm was human immunodeficiency virus negative patients living with diabetes. The expanded English version of the summary of diabetes self-care activities scale was used to measure self-care behaviors. In order to identify the predictors of glycemic control, multivariable Cox regression analysis was used. Statistical significance at p-value ≤ 0.05 was considered.Results: A total of 297 eligible participants were followed for one year, with a mean age of 44.35± 12.55 years. Males accounted for 55.9%. After one year of follow-up, 61.9% of diabetes people living with human immunodeficiency virus, and 49% of human immunodeficiency virus-negative patients with diabetes poorly met blood glucose target (p=0.037). Female gender [AHR: 2.72; 95% CI (1.21– 5.72)], age > 31 years [AHR: 2.48; 95% CI (1.34– 11.01)], increased waist circumference [AHR: 3.64; 95% CI (2.57– 16.12)], overweight [AHR: 3.63; 95% CI (1.65– 22.42)], chronic disease comorbidity [AHR: 2.02; 95% CI (1.44– 2.84)], human immunodeficiency virus infection [AHR: 3.47; 95% CI (2.03– 23.75)], living longer with diabetes (> 5 years) [AHR: 3.67; 95% CI (3.26– 4.14)] showed a higher risk of blood sugar control failure and were independent predictors of uncontrolled glycemia. Tuberculosis infection increased the risk of uncontrolled blood sugar among people living with diabetes and human immunodeficency virus[AHR:3.82;95% CI(2.86-5.84].Conclusion: Significant gaps were observed in achieving the recommended glycemic target and involvement of patients on self-care care behavior in the study area. The co-occurrence of tuberculosis, human immunodeficiency virus, and diabetes is triple trouble needing special attention in their management. It is high time to leverage the clinical care of the looming co-epidemics through chronic comprehensive care clinic.Keywords: human immunodeficiency virus, glycemic control, treatment outcome, self-care behavior |
